Fetalix was selected to participate in the ATiO Emerging Pitch Competition, held in Berlin and organized by the Advanced Therapies in Orthopaedics Foundation. The event brings together innovators, clinicians, and decision-makers focused on the future of musculoskeletal health and regenerative medicine.
Events such as the ATiO Emerging Pitch Competition provide an important platform for early-stage healthcare ventures to gain visibility within specialized medical communities, while also fostering collaboration and accelerating the translation of innovative therapies toward clinical application.
Through this participation, Fetalix had the opportunity to present its regenerative biomaterial technology and its approach to addressing intervertebral disc degeneration and low back pain to an international audience of clinical and industry experts. The session, moderated by Andrew Williamson, featured emerging companies developing advanced therapeutic approaches in orthopaedics and regenerative medicine.
This participation further reinforces Fetalix’s integration within the international innovation ecosystem.
June 25, 2025
